Poly(amidoamine) (PAMAM) dendrimers of generations G0, G1, G2, G3, G4, and G6 are
investigated by potentiometric (acid−base) titrations. The data are interpreted with a site binding model,
which offers the possibility to model the titration curves for all generations of the dendrimers and to
describe all dendrimers within a common parameter set. These parameters involve the microscopic
ionization constants for each group in the fully deprotonated state and nearest-neighbor pair interaction
parameters. From this model we can further obtain all microscopic ionization constants as well as
conditional microstate probabilities. The protonation of PAMAM dendrimers first involves protonation
of primary amine groups at the outer rim of the dendrimer at high pH, while the tertiary amine groups
in the dendrimer core protonate at lower pH. The last group to protonate at low pH is a central tertiary
amine.
Cluster expansion techniques are used to obtain microconstants and microenthalpies of protonation reactions. The approach relies on the analysis of macroscopic protonation constants and protonation enthalpies within a homologous series. Various linear aliphatic polyamines are considered, including 3,4-tri (spermidine), 3,4,3-tet (spermine), and 2,2,2,2-pent. Besides the full resolution of the microscopic protonation equilibria, one obtains information on the temperature dependence of the microstate probabilities. We find that the concentrations of the dominant microspecies increase with increasing temperature. Due to the large negative protonation enthalpies that are typical for amines, higher temperatures generally favor the less protonated species.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.